Asporin (ASPN), a small proteoglycan, mitigates oxidative stress in gastric cancer cells and activates the Rac1 signaling pathway through the upregulation of cluster of differentiation 44 (CD44), thereby enhancing the migratory and invasive capabilities of these cells [91]. This evidence concerns the gene ASPN and gastric cancer.